BioCentury
ARTICLE | Clinical News

Regeneron regulatory update

April 15, 2013 7:00 AM UTC

The University of California (San Francisco) received U.S. Patent No. 5,667,968 covering the use of ciliary neurotrophic factor ( CNTF) to treat retinal diseases such as retinitis pigmentosa and macul...